Literature DB >> 16684946

Torsades de pointes associated with ziprasidone.

Thomas W Heinrich1, Lee A Biblo, John Schneider.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684946     DOI: 10.1176/appi.psy.47.3.264

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  13 in total

1.  QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.

Authors:  Alex F Manini; Dara Raspberry; Robert S Hoffman; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2007-12

Review 2.  Impact of Age and Sex on QT Prolongation in Patients Receiving Psychotropics.

Authors:  Simon W Rabkin
Journal:  Can J Psychiatry       Date:  2015-05       Impact factor: 4.356

Review 3.  Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Brian S Decker; David S Goldfarb; Paul I Dargan; Marjorie Friesen; Sophie Gosselin; Robert S Hoffman; Valéry Lavergne; Thomas D Nolin; Marc Ghannoum
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-12       Impact factor: 8.237

Review 4.  Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder: efficacy and tolerability.

Authors:  Manpreet K Singh; Terence A Ketter; Kiki D Chang
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

5.  QT interval duration and dispersion in children and adolescents treated with ziprasidone.

Authors:  Christoph U Correll; Johnny D Lops; Vicki Figen; Anil K Malhotra; John M Kane; Peter Manu
Journal:  J Clin Psychiatry       Date:  2011-03-08       Impact factor: 4.384

Review 6.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

7.  New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania.

Authors:  Calvert G Warren; Steven L Dubovsky
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-24       Impact factor: 2.570

8.  Critical appraisal of lurasidone in the management of schizophrenia.

Authors:  Silvio Caccia; Luca Pasina; Alessandro Nobili
Journal:  Neuropsychiatr Dis Treat       Date:  2012-04-17       Impact factor: 2.570

9.  Atypical antipsychotic drugs and the risk of sudden cardiac death.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Kathi Hall; C Michael Stein
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 176.079

10.  Ziprasidone in the treatment of mania in bipolar disorder.

Authors:  Stephen E Nicolson; Charles B Nemeroff
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.